Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials

November 17, 2022

https://www.globenewswire.com/news-release/2022/11/17/2558132/0/en/Science-37-and-Linical-Announce-Partnership-to-Enable-Fully-Decentralized-and-Hybrid-Trials.html

RESEARCH TRIANGLE PARK, N.C. and OSAKA, Japan, Nov. 17, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:SNCE), the industry-leading Metasite, and Linical Americas, a U.S. subsidiary of The Linical Group, a leading global contract research organization (CRO), today announced a partnership that will facilitate the deployment of decentralized clinical trial solutions—powered by Science 37—to Linical’s international clients, enabling patient access from virtually anywhere.

Read more at globenewswire.com

Related news for (SNCE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.